Form D · Other Health Care
ChemoMouthpiece, LLC
Wilmington, DE · CIK 0001977151
Offering snapshot reported Oct 30, 2026 · SEC filing
- Reported sold
- $400K Offering amount: $10M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 8, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2026 | Initial | $400,000 | No comparison | 3 | SEC filing |
| Nov 13, 2024 | Initial | $900,000 | No comparison | 1 | SEC filing |
| Sep 26, 2024 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Mar 4, 2024 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-603138
Source: Form D, filed Oct 30, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Ardizzone | Executive |
| Shlomo Lehrman | Director |
| Jeffrey Schwab | Director |
| David Yoskowitz | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3411 Silverside Road
Wilmington, DE, 19810
Wilmington, DE, 19810